Trey Durdin

Memorial Sloan Kettering Cancer Center

Papers

1

Total Citations

4

H-Index

1

About

Dr. Trey Durdin is pioneering the next frontier of surgical precision through fluorescence-guided imaging, with a focused expertise in intraoperative nerve identification. His landmark work on Rizedisben, a novel myelin-binding fluorophore, addresses one of surgery’s most persistent challenges: the inadvertent injury of nerves obscured within tissue. By engineering a compound that fluoresces distinctly under blue light (370-425 nm), Dr. Durdin’s research provides surgeons with a real-time, visual roadmap to spare critical neural structures during minimally invasive procedures. His 2025 study, which has already garnered 4 citations, establishes the foundational safety and efficacy parameters for this technology, marking a critical step toward clinical translation. This work not only promises to reduce post-surgical complications like numbness and paralysis but also sets a new standard for how we visualize and protect delicate anatomy. Dr. Durdin’s contributions are carving a path toward a future where the surgeon’s eye is augmented by molecular specificity, making every dissection safer and more deliberate.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Rizedisben in Minimally Invasive Surgery
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago